Nanostructured Silica Materials As Drug-Delivery Systems for Doxorubicin: Single Molecule and Cellular Studies
- 2 July 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 9 (8) , 2877-2883
Abstract
We apply mesoporous thin silica films with nanometer-sized pores as drug carriers and incorporate the widely used anticancer drug Doxorubicin. Through single-molecule based measurements, we gain mechanistic insights into the drug diffusion inside the mesoporous film, which governs the drug-delivery at the target-site. Drug dynamics inside the nanopores is controlled by pore size and surface modification. The release kinetics is determined and live-cell measurements prove the applicability of the system for drug-delivery. This study demonstrates that mesoporous silica nanomaterials can provide solutions for current challenges in nanomedicine.Keywords
This publication has 30 references indexed in Scilit:
- Liposomal Drug Delivery Systems: An Update ReviewCurrent Drug Delivery, 2007
- Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer DrugsSmall, 2007
- Mesoporous Silica Nanoparticles for Drug Delivery and Biosensing ApplicationsAdvanced Functional Materials, 2007
- Synthesis of sol-gel mesoporous silica materials providing a slow release of doxorubicinJournal of Microencapsulation, 2007
- Micellar Nanocarriers: Pharmaceutical PerspectivesPharmaceutical Research, 2006
- Targeted cancer therapeutics: the heartbreak of successNature Medicine, 2006
- A Mesoporous Silica Nanosphere-Based Carrier System with Chemically Removable CdS Nanoparticle Caps for Stimuli-Responsive Controlled Release of Neurotransmitters and Drug MoleculesJournal of the American Chemical Society, 2003
- Polymeric Systems for Controlled Drug ReleaseChemical Reviews, 1999
- Clinical, toxicological and pharmaceutical aspects of the antineoplastic drug taxol: A reviewClinical Oncology, 1994
- New Methods of Drug DeliveryScience, 1990